<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37951902</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>12</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Evaluation of the Acute flaccid paralysis surveillance indicators in Zambia from 2015-2021: a retrospective analysis.</ArticleTitle><Pagination><StartPage>2227</StartPage><MedlinePgn>2227</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2227</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-023-17141-1</ELocationID><Abstract><AbstractText Label="BACKGROUND">The resurgence of poliovirus infection in previously polio free regions and countries calls for renewed commitment to the global polio eradication efforts including strengthening of Acute Flaccid Paralysis (AFP) surveillance systems. Zambia is one of the countries substantially at risk for the importation of poliovirus infection from neighbouring countries including Malawi, Mozambique, and Democratic Republic of the Congo (DRC). This study describes a seven-year AFP surveillance, assesses the surveillance indicators, and highlights areas for improvement.</AbstractText><AbstractText Label="METHODS">We conducted retrospective analysis of the routinely collected AFP surveillance data from January 2015 to December 2022. The AFP surveillance indicators performance was assessed using the World Health Organisation's recommended minimum AFP surveillance indicators performance.</AbstractText><AbstractText Label="RESULTS">Cumulatively, a total of 1715 AFP cases were reported over the study period. More than half, 891 (52%) of reported cases were aged &lt; 5 years with 917 (53.5%) of males. More than half, 1186 (69.2%) had fever at onset, 718 (41.9%) had asymmetric paralysis and 1164 (67.9%) had their paralysis progressed within 3 days of onset. The non-polio AFP rate ranges from 3.4 to 6.4 per 100,000 children &lt; 15 years old and stool adequacy ranging from 70.9% to 90.2% indicating sensitive surveillance with late detection of cases. The percentage of cases with early stool collection, timely transportation was above the World Health Organisation (WHO) minimum of 80% but with declining proportion of stools arriving in the laboratory in optimal condition. Completeness of 60-days follow-up evaluation was suboptimal ranging from 0.9% to 28.2%.</AbstractText><AbstractText Label="CONCLUSION">The AFP surveillance system in Zambia is doing well. However, additional efforts are needed to improve early detection of cases; stool sample collection, transportation and monitoring to ensure arrival in good condition in the laboratory; and improve 60-days follow-up evaluation for evidenced-based classification of inadequate AFP cases and proper care.</AbstractText><CopyrightInformation>© 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bessing</LastName><ForeName>Barnabas</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office, Lusaka, Zambia. benabala1@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dagoe</LastName><ForeName>Edward A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>United States Centers for Disease Control and Prevention, Atlanta, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tembo</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Zambia National Public Health Institute, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mwangombe</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanyanga</LastName><ForeName>Muzala K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Zambia National Public Health Institute, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manneh</LastName><ForeName>Fadinding</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>World Health Organization Africa Regional Office, Congo Brazzaville, Republic of Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matapo</LastName><ForeName>Belem B</ForeName><Initials>BB</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bobo</LastName><ForeName>Patricia M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Ministry of Health Headquarters, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chipoya</LastName><ForeName>Musole</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>McKing Consulting Corporation, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eboh</LastName><ForeName>Victor A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Taskforce for Global Health, Decatur GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kayeye</LastName><ForeName>Princess L</ForeName><Initials>PL</Initials><AffiliationInfo><Affiliation>Ministry of Health Headquarters, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masumbu</LastName><ForeName>Penelope K</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muzongwe</LastName><ForeName>Chilweza</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Ministry of Health Headquarters, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakyaita</LastName><ForeName>Nathan N</ForeName><Initials>NN</Initials><AffiliationInfo><Affiliation>World Health Organization Country Office, Lusaka, Zambia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zomahoun</LastName><ForeName>Delayo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>United States Centers for Disease Control and Prevention, Atlanta, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>World Health Organization Headquarters, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuma</LastName><ForeName>Jude N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>United States Centers for Disease Control and Prevention, Atlanta, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>World Health Organization Headquarters, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant><Grant><Acronym>CC</Acronym><Agency>CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000509">alpha-Fetoproteins</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000629404">acute flaccid myelitis</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015024" MajorTopicYN="N" Type="Geographic">Zambia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000509" MajorTopicYN="N">alpha-Fetoproteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010243" MajorTopicYN="N">Paralysis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute Flaccid Paralysis</Keyword><Keyword MajorTopicYN="N">Indicators</Keyword><Keyword MajorTopicYN="N">Poliomyelitis</Keyword><Keyword MajorTopicYN="N">Surveillance</Keyword><Keyword MajorTopicYN="N">Zambia</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>12</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>11</Day><Hour>23</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37951902</ArticleId><ArticleId IdType="pmc">PMC10640734</ArticleId><ArticleId IdType="doi">10.1186/s12889-023-17141-1</ArticleId><ArticleId IdType="pii">10.1186/s12889-023-17141-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zerriouh F, Khader Y, Qasem N, et al. Evaluation of the acute flaccid paralysis surveillance system in polio-Free Jordan, 2012–2016: retrospective secondary analysis. JMIR Public Health Surveill. 2019;5(3):e14217. doi: 10.2196/14217.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/14217</ArticleId><ArticleId IdType="pmc">PMC6789419</ArticleId><ArticleId IdType="pubmed">31573938</ArticleId></ArticleIdList></Reference><Reference><Citation>Raji IA, Abubakar AU, Ahmad A, et al. Evaluation of acute flaccid paralysis surveillance indicators in Sokoto state, Nigeria, 2012–2019: a secondary data analysis. BMC Public Health. 2021;21(1):1–9. doi: 10.1186/s12889-021-11238-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-11238-1</ArticleId><ArticleId IdType="pmc">PMC8207697</ArticleId><ArticleId IdType="pubmed">34130684</ArticleId></ArticleIdList></Reference><Reference><Citation>Odoom JK, Ntim NAA, Sarkodie B, et al. Evaluation of AFP surveillance indicators in polio-free Ghana, 2009–2013. BMC Public Health. 2014;14(1):1–8. doi: 10.1186/1471-2458-14-687.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-14-687</ArticleId><ArticleId IdType="pmc">PMC4094438</ArticleId><ArticleId IdType="pubmed">24996415</ArticleId></ArticleIdList></Reference><Reference><Citation>Jasem JA, Marof K, Nawar A, et al. An epidemiological analysis of acute flaccid paralysis and its surveillance system in Iraq, 1997–2011. BMC Infect Dis. 2014;14(1):1–9. doi: 10.1186/1471-2334-14-448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-14-448</ArticleId><ArticleId IdType="pmc">PMC4159501</ArticleId><ArticleId IdType="pubmed">25141887</ArticleId></ArticleIdList></Reference><Reference><Citation>Watkins RE, Martin PAJ, Kelly H, et al. An evaluation of the sensitivity of acute flaccid paralysis surveillance for poliovirus infection in Australia. BMC Infect Dis. 2009;9(1):1–13. doi: 10.1186/1471-2334-9-162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-9-162</ArticleId><ArticleId IdType="pmc">PMC2761398</ArticleId><ArticleId IdType="pubmed">19788763</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochi SL, Freeman A, Guirguis S, et al. Global polio eradication initiative: lessons learned and legacy. J Infect Dis. 2014;210(suppl_1):S540–S46. doi: 10.1093/infdis/jiu345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu345</ArticleId><ArticleId IdType="pmc">PMC10544862</ArticleId><ArticleId IdType="pubmed">25316878</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphreys GJ, McBain AJ. Vaccination and Immunisation. Hugo and Russell's Pharmaceutical Microbiology 2023</Citation></Reference><Reference><Citation>Jil JM, Tegegne AA, Maleghemi S, et al. Acute flaccid paralysis surveillance performance from 2011 to 2020 in Jonglei State, South Sudan: progress and challenges encountered. Pan Afr Med J. 2022;42:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9475046</ArticleId><ArticleId IdType="pubmed">36158927</ArticleId></ArticleIdList></Reference><Reference><Citation>Khuzwayo LS, Kuonza LR, Ngcobo NJ. Evaluating the acute flaccid paralysis surveillance system in South Africa, 2005–2009-an analysis of secondary data. Pan Afr Med J . 2013;14(1):86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3641932</ArticleId><ArticleId IdType="pubmed">23646222</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly H, Brussen KA, Lawrence A, et al. Polioviruses and other enteroviruses isolated from faecal samples of patients with acute flaccid paralysis in Australia, 1996–2004. J Paediatr Child Health. 2006;42(6):370–376. doi: 10.1111/j.1440-1754.2006.00875.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1754.2006.00875.x</ArticleId><ArticleId IdType="pubmed">16737480</ArticleId></ArticleIdList></Reference><Reference><Citation>Tangermann RH, Lamoureux C, Tallis G, et al. The critical role of acute flaccid paralysis surveillance in the Global Polio Eradication Initiative. Int Health. 2017;9(3):156–163. doi: 10.1093/inthealth/ihx016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/inthealth/ihx016</ArticleId><ArticleId IdType="pubmed">28582560</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel MK, Scobie HM, Serhan F, et al. A global comprehensive vaccine-preventable disease surveillance strategy for the immunization Agenda 2030. Vaccine 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10746290</ArticleId><ArticleId IdType="pubmed">38103964</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Recommended Surveillance standards for vaccine-preventable diseases. 2. Geneva: World Health Organization; 2018. p. 7.</Citation></Reference><Reference><Citation>VanderEnde K, Voorman A, Khan S, et al. New analytic approaches for analyzing and presenting polio surveillance data to supplement standard performance indicators. Vaccine X. 2020;4:100059. doi: 10.1016/j.jvacx.2020.100059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvacx.2020.100059</ArticleId><ArticleId IdType="pmc">PMC7090369</ArticleId><ArticleId IdType="pubmed">32215368</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik S, Waheed Y. Tracking down the recent surge of polio virus in endemic and outbreak countries. J Med Virol. 2023;95(1):e28265. doi: 10.1002/jmv.28265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28265</ArticleId><ArticleId IdType="pubmed">36316293</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Notes from the field: Initial outbreak response immunization following wild poliovirus type 1 detection–Malawi, February 2022. Wkly Epidemiol Rec. 2022;97(23):257–259.</Citation></Reference><Reference><Citation>Walker AT, Sodha S, Warren WC, et al. Forewarning of poliovirus outbreaks in the Horn of Africa: an assessment of acute flaccid paralysis surveillance and routine immunization systems in Kenya. J Infect Dis . 2014;210(1):S85–S90. doi: 10.1093/infdis/jiu149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiu149</ArticleId><ArticleId IdType="pmc">PMC4638114</ArticleId><ArticleId IdType="pubmed">25316880</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Best practices in active surveillance for polio eradication. Geneva, Switzerland: World Health Organization; 2018.</Citation></Reference><Reference><Citation>World Health Organization. Global polio surveillance action plan 2022–2024. 2022</Citation></Reference><Reference><Citation>World Health Organisation. Poliomyelitis 2022 [updated 04/07/2022. Available from: https://www.who.int/news-room/fact-sheets/detail/poliomyelitis accessed 08/01/ 2023.</Citation></Reference><Reference><Citation>Tegegne AA, Fiona B, Shebeshi ME, et al. Analysis of acute flaccid paralysis surveillance in Ethiopia, 2005–2015: progress and challenges. Pan Afr Med J. 2017;27(Suppl 2):10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5578723</ArticleId><ArticleId IdType="pubmed">28890751</ArticleId></ArticleIdList></Reference><Reference><Citation>Momen AA, Shakurnia A. An epidemiological analysis of acute flaccid paralysis in Khuzestan Province, southwest Iran, from, 2006 to 2010. Epidemiol Health. 2016;38:e2016030. doi: 10.4178/epih.e2016030.</Citation><ArticleIdList><ArticleId IdType="doi">10.4178/epih.e2016030</ArticleId><ArticleId IdType="pmc">PMC5037358</ArticleId><ArticleId IdType="pubmed">27457060</ArticleId></ArticleIdList></Reference><Reference><Citation>Habib KR. Polio Eradication in Bangladesh: Evaluation of AFP Surveillance Indicators, 2011–2015. Int J Immunol. 2017;5(1):11. doi: 10.11648/j.iji.20170501.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.11648/j.iji.20170501.13</ArticleId></ArticleIdList></Reference><Reference><Citation>Membo HK, Mweene A, Sadeuh-Mba SA, et al. Acute flaccid paralysis surveillance indicators in the Democratic Republic of Congo during 2008–2014. Pan Afr Med J . 2016;24(1):154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5012780</ArticleId><ArticleId IdType="pubmed">27642491</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirambo R, Baboo K, Siziya S. Performance of acute flaccid paralysis surveillance system in Zambia: 2000 to 2009-analysis of secondary data. Int J Public Health Epidemiol. 2014;3(10):075–81.</Citation></Reference><Reference><Citation>World Health Organization. Best practices in active surveillance for polio eradication, Geneva:2018 [Available from: https://polioeradication.org/wp-content/uploads/2018/12/Best-practices-in-active-surveillance-for-polio-eradication.pdf accessed 08/01/ 2023.</Citation></Reference><Reference><Citation>Manyanga D, Byabamazima C, Masvikeni B, et al. Assessment of acute flaccid paralysis surveillance performance in East and Southern African countries 2012–2019. Pan Afr Med J. 2020;36(1):71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7380870</ArticleId><ArticleId IdType="pubmed">32754298</ArticleId></ArticleIdList></Reference><Reference><Citation>Manyanga D, Masvikeni B, Kuloba M, et al. Early effects of the COVID-19 pandemic on the acute flaccid paralysis surveillance in East and Southern African countries. Pan Afr Med J. 2021;39(1):147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8418164</ArticleId><ArticleId IdType="pubmed">34527163</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>